Clinical Trial Update: Cesium-131 Seed Brachytherapy Plus Subtotal Resection for Lung Cancer Patients [NA]

View source ↗

Summary

The clinical trial investigating cesium-131 seed brachytherapy with subtotal resection for lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Lung Cancer | NA | Status: WITHDRAWN